Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_provenance.
- NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_assertion description "[We examine the long-term effects of a thyrotropin-releasing hormone (TRH) analogue, CNK-602A, acute administration of which was effective inhibiting both types of seizures in SER, to determine if this agent could be used to treat epilepsy for long periods.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_provenance.
- NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_assertion evidence source_evidence_literature NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_provenance.
- NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_assertion SIO_000772 8603636 NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_provenance.
- NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_assertion wasDerivedFrom befree-20150227 NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_provenance.
- NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_assertion wasGeneratedBy ECO_0000203 NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP758001.RAR8Tx4mxteEe6G0DsRrWQ46X9S1iD-38VdznGs00XitA130_provenance.